miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2

被引:113
|
作者
Chen, Lingchao [1 ]
Wang, Xiaofeng [1 ]
Wang, Hanbing [1 ]
Li, Yongli [1 ]
Yan, Wei [4 ]
Han, Lei [2 ,3 ,5 ]
Zhang, Kailiang [2 ,3 ,5 ]
Zhang, Junxia [2 ,3 ,5 ]
Wang, Yongzhi [4 ]
Feng, Yan [1 ]
Pu, Peiyu [2 ,3 ,5 ]
Jiang, Tao [4 ]
Kang, Chunsheng [2 ,3 ,5 ]
Jiang, Chuanlu [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin 150086, Peoples R China
[2] Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurosurg, Gen Hosp,Lab Neurooncol, Tianjin 300060, Peoples R China
[3] Minist Educ, Key Lab Neurotrauma Variat & Regenerat, Tianjin 300060, Peoples R China
[4] Capital Med Univ, Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China
[5] Tianjin Municipal Govt, Tianjin 300060, Peoples R China
关键词
miR-137; Glioma; Cox-2; EXPRESSION; CYCLOOXYGENASE-2; MICRORNAS; CANCER; GLIOMA; SIGNATURES; ROLES;
D O I
10.1016/j.ejca.2012.02.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs are strongly implicated in cancer but their specific roles and functions in the major cancers have yet to be fully elucidated. In this study, we defined the expression and function of miR-137, which we found to be downregulated in glioma samples and glioma cells by qRT-PCR. Ectopic expression of miR-137 in glioma cell lines inhibited proliferation and invasion. Using computational and expression analysis, Cox-2 was identified as a candidate target of miR-137. Reporter assay with 30UTR of Cox-2 cloned downstream of the luciferase gene showed reduced luciferase activity in the presence of miR-137, providing strong evidence that miR-137 was a direct regulator of Cox-2. Expression analysis further revealed that Cox-2 was elevated in glioma and associated with survival of patients. Furthermore, we observed that Cox-2 knockdown resulted in effects similar to those with miR-137 transfection in glioma cells. In conclusion, our study demonstrates that miR-137 deregulation is common in glioma, and restoration of its function inhibits cell proliferation and invasion, suggesting that miR-137 may act as a tumour suppressor. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3104 / 3111
页数:8
相关论文
共 50 条
  • [22] Arabidopsis RAV1 is down-regulated by brassinosteroid and may act as a negative regulator during plant development
    Hu, YX
    Wang, YH
    Liu, XF
    Li, JY
    CELL RESEARCH, 2004, 14 (01) : 8 - 15
  • [23] Arabidopsis RAV1 is down-regulated by brassinosteroid and may act as a negative regulator during plant development
    Yu Xin HU
    Yong Hong WANG
    Xin Fang LIU
    Jia Yang LI
    Cell Research, 2004, 14 : 8 - 15
  • [24] Necdin, a Negative Growth Regulator, Is a Novel STAT3 Target Gene Down-Regulated in Human Cancer
    Haviland, Rachel
    Eschrich, Steven
    Bloom, Gregory
    Ma, Yihong
    Minton, Susan
    Jove, Richard
    Cress, W. Douglas
    PLOS ONE, 2011, 6 (10):
  • [25] Neuronal pentraxin II (NPTX2) Is Frequently Down-Regulated by Promoter Hypermethylation in Pancreatic Cancers
    Ling Zhang
    Jun Gao
    Zhaoshen Li
    Yanfang Gong
    Digestive Diseases and Sciences, 2012, 57 : 2608 - 2614
  • [26] MiR-22 is frequently down-regulated in medulloblastomas, and inhibits cell proliferation via the novel target PAPST1
    Xu, Qing-Fu
    Pang, Jesse Chung-Sean
    Yang, Hui
    Lv, Sheng-Qing
    Ohgaki, Hiroko
    CANCER RESEARCH, 2014, 74 (19)
  • [27] Neuronal pentraxin II (NPTX2) Is Frequently Down-Regulated by Promoter Hypermethylation in Pancreatic Cancers
    Zhang, Ling
    Gao, Jun
    Li, Zhaoshen
    Gong, Yanfang
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (10) : 2608 - 2614
  • [28] Translational Repression of Down-Regulated in Adenoma by miR-494 in Caco2 Cells
    Anbazhagan, Arivarasu N.
    Priyamvada, Shubha
    Tyagi, Sangeeta
    Maher, Daniel B.
    Kumar, Anoop
    Borthakur, Alip
    Alrefai, Waddah A.
    Kwon, John
    Dudeja, Pradeep K.
    FASEB JOURNAL, 2012, 26
  • [29] MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy
    Krell, A.
    Wolter, M.
    Stojcheva, N.
    Hertler, C.
    Liesenberg, F.
    Zapatka, M.
    Weller, M.
    Malzkorn, B.
    Reifenberger, G.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2019, 45 (05) : 441 - 458
  • [30] Circulating and visceral adipose miR-100 is down-regulated in patients with obesity and Type 2 diabetes
    Pek, Sharon Li Ting
    Sum, Chee Fang
    Lin, Michelle Xueqin
    Cheng, Anton Kui Sing
    Wong, Michael Tack Keong
    Lim, Su Chi
    Tavintharan, Subramaniam
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2016, 427 (0C) : 112 - 123